In summary, it was identified that TP73-AS1 could promote HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation; TP73-AS1 might compete with HMGB1 for miR-200a binding to inhibit miR-200a expression. Here, TP73 is linked to hepatocellular carcinoma.